Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

@article{Griffin2013AntidonorIR,
  title={Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?},
  author={Matthew D Griffin and Aideen E Ryan and Senthilkumar Alagesan and Paul Lohan and Oliver Treacy and Thomas Ritter},
  journal={Immunology and cell biology},
  year={2013},
  volume={91 1},
  pages={
          40-51
        }
}
Mesenchymal stem (stromal) cells (MSCs) have potent anti-inflammatory/immunosuppressive properties which underlie much of their therapeutic potential. This fact has led to the widely accepted belief that MSCs from genetically unrelated individuals (allogeneic (allo)-MSCs) can be used therapeutically with equal efficacy to autologous MSCs and without triggering the donor-specific immune responses that are typically associated with allo-transplants. In this article, we critically review available… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS

From This Paper

Topics from this paper.
68 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 68 extracted citations

Similar Papers

Loading similar papers…